Projects
Freiburg Research Data Tool - Fredato
With the Freiburg research data tool - Fredato, the research data management group offers a user-friendly interface for storing and managing research data. The advantages of the functionalities of GitLab are integrated with the simple cloud storage service Nextcloud and supplemented by additional services such as the collection of metadata.
fredato is in operation and is continuously being further developed and supplemented with new components. In doing so, the platform is currently only available to project partners. With the feedback of the researchers involved, the platform will be successively adapted to the needs of the scientists.
The Research Data Management is involved in the Infrastructure Project (INF) and coordinates data management within the various Collaborative Research Centers (CRC).
The Deutsche Forschungsgemeinschaft (DFG) is funding the new Collaborative Research Center (CRC) 1597 Small Data with more than 11 million euros from October 2023 to June 2027. Headed by Prof. Dr. Harald Binder, the CRC will develop methods to discover complex patterns in small data sets using AI techniques and modeling. The interdisciplinary approach involves collaboration between computer science, mathematics, statistics, biomedicine and systems modeling.
CRC 1425 "Heterocellular Nature of Cardiac Lesion: Identities, Interactions, Implications" under the leadership of the Institute of Experimental Cardiovascular Medicine (IEKM) received a four-year grant from the DFG. In contrast to traditional cardiac research, the project, which has been funded since July 2020, focuses on non-myocytes, their interaction with cardiomyocytes and the control of repair processes.
OncoEscape has been funded by the DFG with eleven million euros since July 2021. Here, researchers from the University Medical Center Freiburg, the Albert Ludwig University Freiburg, the Max Planck Institute of Immunobiology and Epigenetics in Freiburg, the German Cancer Research Center in Heidelberg and the Georg-Speyer Haus in Frankfurt are investigating how certain genetic characteristics first contribute to the development of tumor cells and later to their escape from the immune system.
The IMPATH project, which is in its third funding phase, investigates a weak immune response as a cause of immunopathology, i.e., malfunction of the immune system. The "IMPATH paradox", that a disturbed immune response is an essential prerequisite for immunopathology, was brought to the fore in the first funding period. Now, the focus will be on the molecular mechanisms underlying impaired immune responses and resulting immunopathology.
Pressemitteilung (third funding phase2023)
Pressemitteilung (second funding phase 2019)
CRC 1453 (NephGen) received DFG funding of 13.5 million euros in 2021 for a period of four years. The central goal is to improve the treatment and prevention of kidney diseases. [...] Suitable pharmaceutical agents will be sought on the basis of the identification of suitable target structures in the kidney cells.
Since January 2023, the Transregio PILOT project has received funding from the DFG of around 12 million euros for four years. It investigates how a child's immune system develops around birth. Researchers from the Medical Faculty of the University of Freiburg are collaborating with LMU Munich, RWTH Aachen University Hospital and others.
Institute of Medical Biometry and Statistics
Research Data Management
Stefan-Meier Str. 26, 79104 Freiburg im Breisgau